Chemagic 360 servicing for Cambridge genetics comes from Revvity
- Cambridge University Hospitals NHS Foundation Trust
- East of England
- Below threshold - unknown
- 10 August 2026 to 9 August 2027
Cambridge University Hospitals NHS Foundation Trust bought servicing from Revvity for two Chemagic 360 instruments used in its genetics work.
The cover is a Signature Plus Service plan, which takes in maintenance of both instruments.
The trust placed the £20,130 order in August 2026, and the plan runs for a year, to August 2027.
Contract ends August 2027
- What
- PCR and molecular diagnostic platforms
- Supplier
- Revvity
- Value
- £20,130
- How it was bought
- Below threshold - unknown
- Dates and next
- Aug 2026 to Aug 2027
- Being re-tendered now